Endoglin Antibodies

Santa Cruz Biotechnology features a diverse variety of Endoglin Antibodies for advanced research in vascular biology and angiogenesis. Endoglin Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Endoglin, also known as CD105, is a co-receptor for transforming growth factor-beta (TGF-β) and plays a critical role in endothelial cell proliferation and migration during angiogenesis. Understanding Endoglin's function is essential for normal vascular development research. Endoglin expression patterns can reveal important insights into various pathological conditions, including cancer and cardiovascular diseases. Investigating Endoglin helps researchers uncover mechanisms of vascular remodeling and identify potential therapeutic targets. Detailed characterization of Endoglin's molecular interactions provides valuable information about blood vessel formation and maintenance. Research using Endoglin monoclonal antibodies contributes significantly to advancing vascular biology knowledge. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in their mission to understand vascular development and disease mechanisms.